Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Savaria Presents its Fourth Quarter and 2024 Results

In This Article:

Savaria Corporation
Savaria Corporation

LAVAL, Québec, March 05, 2025 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for fiscal 2024.

Highlights – Fiscal 2024 compared to 2023

  • Revenue was $867.8M, up $30.8M or 3.7%, mainly due to organic growth of 3.7% and a positive foreign exchange impact of 1.4%, partially offset by the divestitures of Van-Action, Freedom Motors and the operations in Norway, net of the acquisition of Matot.

    • Accessibility organic growth stood at 3.4%, including growth of 8.4% coming from North America and partially offset by a contraction of 2.5% in Europe.

    • Patient Care organic revenue increased by 4.5%.

  • Gross profit was $321.7M, up $35.7M or 12.5%, representing 37.1% of revenue, an increase of 290 bps compared to 34.2% in 2023.

  • Operating income was $84.1M, up $12.0M or 16.6%, representing 9.7% of revenue compared to 8.6% in 2023.

  • Adjusted EBITDA* was $161.2M, up $31.2M or 24.0%, representing $2.25 per share, up $0.30.

  • Adjusted EBITDA margin* stood at 18.6% up 310 bps compared to 15.5% in 2023.

    • Accessibility adjusted EBITDA margin reached 19.8%.

    • Patient Care adjusted EBITDA margin stood at 19.1%.

  • Net earnings were $48.5M or $0.68 per share on a diluted basis, compared to $37.8M or $0.57 per share in 2023.

  • The ratio of net debt to adjusted EBITDA* stood at 1.63 in comparison to 2.07 as at December 31, 2023.

  • Available funds* of $242.8M to support working capital, investments and growth opportunities.

 

Q4

YTD

in thousands of dollars, except per-share amounts

2024

2023

Change

2024

2023

Change

Revenue

$

223,340

 

$

216,839

 

 

3.0

%

$

867,762

 

$

836,954

 

 

3.7

%

Gross profit

$

84,224

 

$

74,322

 

 

13.3

%

$

321,712

 

$

286,020

 

 

12.5

%

% of revenue

 

37.7

%

 

34.3

%

 

340

bps

 

37.1

%

 

34.2

%

 

290

bps

Operating income

$

21,772

 

$

19,843

 

 

9.7

%

$

84,137

 

$

72,150

 

 

16.6

%

Net earnings

$

14,333

 

$

10,959

 

 

30.8

%

$

48,510

 

$

37,841

 

 

28.2

%

Diluted net earnings per share

$

0.20

 

$

0.16

 

 

25.0

%

$

0.68

 

$

0.57

 

 

19.3

%

Adjusted net earnings*

$

19,269

 

$

12,848

 

 

50.0

%

$

64,795

 

$

42,909

 

 

51.0

%

Adjusted net earnings per share*

$

0.26

 

$

0.19

 

 

36.8

%

$

0.90

 

$

0.65

 

 

38.5

%

Adjusted EBITDA*

$

42,867

 

$

35,105

 

 

22.1

%

$

161,230

 

$

130,075

 

 

24.0

%

Adjusted EBITDA per share*

$

0.59

 

$

0.49

 

 

20.4

%

$

2.25

 

$

1.95

 

 

15.4

%

% of revenue

 

19.2

%

 

16.2

%

 

300

bps

 

18.6

%

 

15.5

%

 

310

bps

*Non-IFRS measures are described and reconciled in sections 3, 6 and 8 of the MD&A.